Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteria.
about
Current Trends in Development of Liposomes for Targeting Bacterial BiofilmsNovel formulations for antimicrobial peptidesInhalable Antimicrobials for Treatment of Bacterial Biofilm-Associated Sinusitis in Cystic Fibrosis Patients: Challenges and Drug Delivery Approaches.Nanomedicine in the Management of Microbial Infection - Overview and PerspectivesPotent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii.Anti-Adhesion Activity of A2-type Proanthocyanidins (a Cranberry Major Component) on Uropathogenic E. coli and P. mirabilis Strains.Preparation, characterization and in vitro antimicrobial activity of liposomal ceftazidime and cefepime against Pseudomonas aeruginosa strains.Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.Liposomal antibiotics for the treatment of infectious diseases.Potential strategies for the eradication of multidrug-resistant Gram-negative bacterial infections.Artificial bacterial flagella for remote-controlled targeted single-cell drug delivery.Tat-functionalized liposomes for the treatment of meningitis: an in vitro study.Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii.Enhanced bactericidal potency of nanoliposomes by modification of the fusion activity between liposomes and bacterium.Triclosan resistance reversion by encapsulation in chitosan-coated-nanocapsule containing α-bisabolol as core: development of wound dressing.Optimization of niosomes for enhanced antibacterial activity and reduced bacterial resistance: in vitro and in vivo evaluation.Antimicrobial Peptides and Nanotechnology, Recent Advances and Challenges.Enhanced Efficacy and Broadening of Antibacterial Action of Drugs via the Use of Capped Mesoporous Nanoparticles
P2860
Q26865495-5E2931A7-072C-4FF3-9C74-72F4C064C8B5Q26991771-6C842C21-DAEC-455C-B222-AB6737CB5F7EQ28077482-1F641FED-0330-46D6-89B3-354DA005DCBFQ34245494-BE70F57C-0503-41A7-AD72-378BB3B4F5B8Q34309445-D82C5F8E-DE28-4EFF-A49A-9473D1EF86D1Q36683711-7A520E06-0EB3-461D-9F9B-C6E2C0034BC1Q37159968-F42A39BA-4C02-4337-8CDD-88F1B617A428Q37869910-9296AB07-985E-4C68-B6D4-AB5835E88A0AQ38124144-7230BAED-9D1D-48AE-B8F8-A37C96A24D3FQ38847017-23B62870-746B-48C1-86E7-77D77C29B990Q39016626-62CF0C1D-46E6-48E8-A1BE-AF207E25165DQ40227991-3FCF8B65-40E4-4924-AF27-0CFA320F9FCCQ41736250-FEE17C1D-ECBD-488C-97C0-7E430C30EFAAQ43106760-DCF8A56F-6863-4DDE-9141-53608D000A8DQ43807100-A2E23E71-F500-4E3B-94F6-96C326D8B766Q46202238-4AD8A479-0AEF-4788-9268-156C940F5D6CQ55053689-C2FA855A-F9C9-4CC7-A5C9-50AE4A33B05CQ57401132-2C72DFD0-1AEE-4A59-A379-866EA0CE722A
P2860
Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteria.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Encapsulation in fusogenic lip ...... gainst Gram-negative bacteria.
@en
Encapsulation in fusogenic lip ...... gainst Gram-negative bacteria.
@nl
type
label
Encapsulation in fusogenic lip ...... gainst Gram-negative bacteria.
@en
Encapsulation in fusogenic lip ...... gainst Gram-negative bacteria.
@nl
prefLabel
Encapsulation in fusogenic lip ...... gainst Gram-negative bacteria.
@en
Encapsulation in fusogenic lip ...... gainst Gram-negative bacteria.
@nl
P1476
Encapsulation in fusogenic lip ...... against Gram-negative bacteria
@en
P2093
Daria Nicolosi
Vito M Nicolosi
P304
P356
10.1016/J.IJANTIMICAG.2010.01.015
P577
2010-03-09T00:00:00Z